THE RISK AND BURDEN OF THROMBOEMBOLIC AND HEMORRHAGIC EVENTS IN PATIENTS WITH MALIGNANT GLIOMA RECEIVING BEVACIZUMAB

被引：0
|
作者：
Ou, Alexander [1 ]
Lin, Heather [1 ]
Yuan, Ying [1 ]
Bornstein, Charles [1 ]
Alfaro-Munoz, Kristin [1 ]
Afshar-Kharghan, Vahid [1 ]
Kamiya-Matsuoka, Carlos [1 ]
Majd, Nazanin [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NCMP-06
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab
    Pushan Dasgupta
    Alexander Ou
    Heather Lin
    Timothy Gregory
    Kristin D. Alfaro-Munoz
    Ying Yuan
    Vahid Afshar-Khargan
    Carlos Kamiya-Matsuoka
    Justin F. Rousseau
    Nazanin K. Majd
    [J]. Journal of Neuro-Oncology, 2024, 167 : 181 - 188
  • [2] The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab
    Dasgupta, Pushan
    Ou, Alexander
    Lin, Heather
    Gregory, Timothy
    Alfaro-Munoz, Kristin D.
    Yuan, Ying
    Afshar-Khargan, Vahid
    Kamiya-Matsuoka, Carlos
    Rousseau, Justin F.
    Majd, Nazanin K.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2024, 167 (01) : 181 - 188
  • [3] Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
    Tebbutt, N. C.
    Murphy, F.
    Zannino, D.
    Wilson, K.
    Cummins, M. M.
    Abdi, E.
    Strickland, A. H.
    Lowenthal, R. M.
    Marx, G.
    Karapetis, C.
    Shannon, J.
    Goldstein, D.
    Nayagam, S. S.
    Blum, R.
    Chantrill, L.
    Simes, R. J.
    Price, T. J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1834 - 1838
  • [4] D-Dimer Elevation and Paresis Predict Thromboembolic Events During Bevacizumab Therapy for Recurrent Malignant Glioma
    Misch, Martin
    Czabanka, Marcus
    Dengler, Julius
    Stoffels, Mandy
    Auf, Gregor
    Vajkoczy, Peter
    Stockhammer, Florian
    [J]. ANTICANCER RESEARCH, 2013, 33 (05) : 2093 - 2098
  • [5] Thromboembolic events in brain tumour patients on bevacizumab
    Singh, Gunjesh Kumar
    Menon, Nandini
    Jadhav, Monica Madhusing
    Walavalkar, Rutuja
    DSouza, Hollis
    Roy, Somnath
    Das, Sudeep
    Srinivas, Sujay
    Vallathol, Dilip Harindran
    Patil, Vijay M.
    [J]. ACTA ONCOLOGICA, 2020, 59 (12) : 1543 - 1546
  • [6] Thromboembolic events in brain tumour patients on bevacizumab
    Singh, G. K.
    Menon, N.
    Jadhav, M. M.
    Walavalkar, R.
    Dsouza, H.
    Roy, S.
    Das, S.
    Srinivas, S. Sujay
    Vallathol, D. H.
    Patil, V. M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1374 - S1375
  • [7] Risk factors for thromboembolic events in testicular cancer patients receiving chemotherapy
    Shim, K.
    Potvin, K. R.
    Mills, K.
    Whiston, F.
    Stitt, L.
    Winquist, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Bevacizumab + chemotherapy increases risk of arterial thromboembolic events
    [J]. Reactions Weekly, 2005, 1056 (1) : 5 - 5
  • [9] Cerebrovascular Events in Glioma Patients Treated with Bevacizumab
    Patel, Donika K.
    John, Seby
    Hashemi-Sadraei, Neda
    Ahluwalia, Manmeet
    [J]. STROKE, 2013, 44 (02)
  • [10] Cerebrovascular Events in Glioma Patients Treated with Bevacizumab
    Patel, Donika
    John, Seby
    Hashemi-Sadraei, Neda
    Ahluwalia, Manmeet
    [J]. NEUROLOGY, 2013, 80
12345